[Induction of a viral expression by 5-bromodeoxyuridine (BUdR) and 5-iododeoxyuridine (IUdR), in cell lines derived from Burkitt's lymphoma and rhinopharyngeal cancers].
D000941:Antigens / Q000096:biosynthesis*; D000956:Antigens, Viral / Q000096:biosynthesis; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002051:Burkitt Lymphoma; D002460:Cell Line / Q000187:drug effects* / Q000276:immunology / Q000382:microbiology; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D006564:Herpesviridae / Q000276:immunology*; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology*; D008214:Lymphocytes; D009303:Nasopharyngeal Neoplasms; D013997:Time Factors; D014779:Virus Replication / Q000187:drug effects
D000941:Antigens; D000956:Antigens, Viral; D001973:Bromodeoxyuridine; D007065:Idoxuridine
Induction d'une expression viral par le 5-bromodeoxyuridine (BUdR) et le 5-iododeoxyuridine (IUdR), dans des lignées issues de lymphomes de Burkitt et de cancers du rhinopharynx.